ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Multidimensional evaluation of clinical and functional impairment in a large population of patients with Charcot-Marie-Tooth.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Charcot-Marie-Tooth (CMT) disease is one of the most common inherited neuropathies, leading progressive muscular weakness, pes cavus, loss of deep tendon reflexes, distal sensory loss, and gait impairment. Charcot Marie Tooth Neuropathy Scale (CMTNS) represents the gold standard to assess and grade the impairment in CMT patients. The aim of this retrospective study was to assess the correlation between CMTNS and functional status in CMT patients. We analyzed data of patients with diagnosis of CMT, collecting the following data: age; gender; BMI; CMT type (Demyelinating- Axonal- Other or mixed forms); Time from diagnosis; Charcot-Marie-Tooth Disease Neuropathy Score (CMTNS); MEDICAL RESEARCH COUNCIL lower limb sum-score (MRCLL-SS); MEDICAL RESEARCH COUNCIL Upper Limb Sum Core (MRCUL-SS); Manual Ability Measure-16 (MAM-16); Berg Balance Scale (BBS); Walking Handicap Scale (WHS); Walk-12; Rankin Scale; Modified Fatigue Impact Scale (MFIS); Visual Analogic Scale (VAS); 10 m Walking test. We included 235 patients with a mean age of 45.77 ± 15 years. All variables, excluded VAS and MFIS, showed a statistically significant correlation with CMTNS. In particular, a moderate negative correlation was found between CMTNS and MRCLL-SS (r = -0.47), and Berg Balance scale (r = - 0.61); A moderate positive correlation was found between CMTNS and Rankin scale (r = 0.53), and walk 12 (r = 0.41). Taken together, these findings suggest that CMTNS is a valuable tool to detect the severity of disability and limbs function in CMT patients.
Indexed as
Identifiers
41100006What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.